Raboral V-RG, suukaudne suspensioon rebastele
Raboral V-RG, suukaudne suspensioon rebastele
Authorised
- Rabies virus, Live
Product identification
Medicine name:
Raboral V-RG, suukaudne suspensioon rebastele
Active substance:
- Rabies virus, Live
Target species:
-
Fox
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, Live100000000.00/cell culture infective dose 501.00dose
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Fox
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- RAVIMIAMET
Authorisation number:
- 1251
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 6/04/2022
How useful was this page?:
